Canada G6V 3Z1
Information non disponible
Dosing of Cannabinoids Associated with an Opioid-Sparing Effect: A Systematic Review of Longitudinal StudiesArticle de revue
Pain Manag Nurs, 2023.
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water suppliesArticle de revue
Br J Clin Pharmacol, 89 (7), 2023.
Changes in self-rated physical and mental health and life satisfaction associated with opioid and potentially inappropriate opioid prescribing in primary care older adultsArticle de revue
Fam Pract, 2023.
Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016Article de revue
Front Pharmacol, 14 , 2023.
Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-CanadianArticle de revue
Can J Aging, 42 (1), 2023.
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older PeopleArticle de revue
Pharmaceuticals (Basel), 15 (8), 2022.
Factors associated with potentially inappropriate opioid use in community-living older adults consulting in primary careArticle de revue
Int J Geriatr Psychiatry, 37 (8), 2022.
Global prevalence of antidepressant drug utilization in the community: protocol for a systematic reviewArticle de revue
BMJ Open, 12 (5), 2022.
What methods are used to study the association between medication adherence trajectories, estimated with the group-based trajectory modeling (GBTM) method, and health-related outcomes?-a protocol for a systematic reviewArticle de revue
Syst Rev, 11 (1), 2022.
Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatmentArticle de revue
Diabetes Metab, 48 (4), 2022.